Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

NOVA1 Antikörper (AA 295-510)

NOVA1 Reaktivität: Human WB, IHC, ICC, IP Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN7444868
  • Target Alle NOVA1 Antikörper anzeigen
    NOVA1 (Neuro-Oncological Ventral Antigen 1 (NOVA1))
    Bindungsspezifität
    • 15
    • 6
    • 4
    • 4
    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 295-510
    Reaktivität
    • 45
    • 24
    • 20
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    Human
    Wirt
    • 34
    • 10
    • 1
    Kaninchen
    Klonalität
    • 36
    • 9
    Polyklonal
    Konjugat
    • 27
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser NOVA1 Antikörper ist unkonjugiert
    Applikation
    • 35
    • 15
    • 13
    • 13
    • 8
    • 7
    • 4
    • 4
    • 4
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunoprecipitation (IP)
    Verwendungszweck
    Polyclonal Antibody to Neuro Oncological Ventral Antigen 1 (NOVA1)
    Spezifität
    The antibody is a rabbit polyclonal antibody raised against NOVA1. It has been selected for its ability to recognize NOVA1 in immunohistochemical staining and western blotting.
    Kreuzreaktivität
    Maus, Schwein, Ratte
    Aufreinigung
    Antigen-specific affinity chromatography followed by Protein A affinity chromatography
    Immunogen
    Recombinant Neuro Oncological Ventral Antigen 1 (NOVA1) corresdonding to Ala295~Gly510 with N-terminal His Tag
    Isotyp
    IgG
  • Applikationshinweise

    Western blotting: 0.5-2 μg/mL

    1:270-1100 Immunohistochemistry: 5-20 μg/mL

    1:27-110 Immunocytochemistry: 5-20 μg/mL

    1:27-110 Optimal working dilutions must be determined by end user.

    Kommentare

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
    Haltbarkeit
    24 months
  • Target
    NOVA1 (Neuro-Oncological Ventral Antigen 1 (NOVA1))
    Andere Bezeichnung
    Neuro Oncological Ventral Antigen 1 (NOVA1 Produkte)
    Synonyme
    Nova-1 antikoerper, NOVA1 antikoerper, si:ch211-222c22.9 antikoerper, 9430099M15Rik antikoerper, G630039L02 antikoerper, NOVA alternative splicing regulator 1 antikoerper, neuro-oncological ventral antigen 1 L homeolog antikoerper, neuro-oncological ventral antigen 1 antikoerper, RNA-binding protein Nova-1 antikoerper, lipid A export ATP-binding/permease protein antikoerper, NOVA1 antikoerper, Nova1 antikoerper, nova1.L antikoerper, nova1 antikoerper, LOC790874 antikoerper, novA1 antikoerper
    Hintergrund
    Onconeural ventral antigen 1, Paraneoplastic Ri antigen, Ventral neuron-specific protein 1, RNA-binding protein Nova-1
Sie sind hier:
Kundenservice